Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

Status: Recruiting
Location: See all (9) locations...
Study Type: Observational
SUMMARY

The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.

Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:

• Patients diagnosed with cervical neuroendocrine carcinoma by histopathology

• Clinical data were complete

Locations
Other Locations
China
Xiangya Hospital, Central South University
RECRUITING
Changsha
Fujian Maternity and Child Health Hospital
RECRUITING
Fuzhou
Fujian Provincial Hospital
RECRUITING
Fuzhou
Jiangxi maternal and Child Health Hospital
RECRUITING
Nanchang
Ningde Mindong Hospital
RECRUITING
Ningde
Putian City first Hospital
RECRUITING
Putian
The Second Affiliated Hospital of Fujian Medical University
RECRUITING
Quanzhou
Maternal and Child Health Hospital of Hubei Province
RECRUITING
Wuhan
Zhangzhou affiliated Hospital of Fujian Medical University
RECRUITING
Zhangzhou
Contact Information
Primary
Binhua Dong
dongbinhua86@fjmu.edu.cn
+86-0591-87558732
Backup
Pengming Sun
fmsun1975@fjmu.edu.cn
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2025-02-28
Participants
Target number of participants: 300
Sponsors
Leads: Fujian Maternity and Child Health Hospital

This content was sourced from clinicaltrials.gov